Effect of BDNF and Other Potential Survival Factors in Models of in Vitro Oxidative Stress on Adult Spinal Cord-Derived Neural Stem/Progenitor Cells

BioResearch Open Access

Volumn 4, Issue 1, 2015, Pages 146-159

  Hachem, Laureen D ^a   Mothe, Andrea J ^a   Tator, Charles H ^a,b  

^a TORONTO WESTERN HOSPITAL   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

Author keywords

antioxidants; cell culture; growth factor; neural stem cells; oxidative stress

Indexed keywords

BRAIN DERIVED NEUROTROPHIC FACTOR; CYCLOSPORIN A; GLUTATHIONE REDUCTASE; HYDROGEN PEROXIDE; PROTIRELIN; REACTIVE OXYGEN METABOLITE; SUPEROXIDE DISMUTASE;

ADULT; ADULT STEM CELL; ANIMAL CELL; ANIMAL TISSUE; ANTIOXIDANT ACTIVITY; APOPTOSIS; ARTICLE; CELL DAMAGE; CELL DIFFERENTIATION; CELL PROLIFERATION; CELL SURVIVAL; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG EFFICACY; ENZYME ACTIVITY; IN VITRO STUDY; INTRACELLULAR SIGNALING; NEURAL STEM CELL; NEUROPROTECTION; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; RAT; SPINAL CORD; SURVIVAL FACTOR;

EID: 85009112869     PISSN: None     EISSN: 21647860     Source Type: Journal    
DOI: 10.1089/biores.2014.0058     Document Type: Article

References (61)

1. Mothe AJ, Tator CH. Advances in stem cell therapy for spinal cord injury. J Clin Invest. 2012;122:3824-3834.
2. Mothe AJ, Tator CH. Review of transplantation of neural stem/progenitor cells for spinal cord injury. Int J Dev Neurosci. 2013;31:701-713.
3. Rossi SL, Keirstead HS. Stem cells and spinal cord regeneration. Curr Opin Biotechnol. 2009;20:552-562.
4. Weiss S, Dunne C, Hewson J, et al. Multipotent CNS stem cells are present in the adult mammalian spinal cord and ventricular neuroaxis. J Neurosci. 1996;16:7599-7609.
5. Parr AM, Kulbatski I, Zahir T, et al. Transplanted adult spinal cord-derived neural stem/progenitor cells promote early functional recovery after rat spinal cord injury. Neuroscience. 2008;155:760-770.
6. Karimi-Abdolrezaee S, Eftekharpour E, Wang J, et al. Delayed transplantation of adult neural precursor cells promotes remyelination and functional neurological recovery after spinal cord injury. J Neurosci. 2006;26:3377-3389.
7. Hawryluk GW, Mothe A, Wang J, et al. An in vivo characterization of trophic factor production following neural precursor cell or bone marrow stromal cell transplantation for spinal cord injury. Stem Cells Dev. 2012; 21:2222-2238.
8. Mothe AJ, Tam RY, Zahir T, et al. Repair of the injured spinal cord by transplantation of neural stem cells in a hyaluronan-based hydrogel. Biomaterials. 2013;34:3775-3783.
9. Okada S, Ishii K, Yamane J, et al. In vivo imaging of engrafted neural stem cells: its application in evaluating the optimal timing of transplantation for spinal cord injury. FASEB J. 2005;19:1839-1841.
10. Hsieh WY, Hsieh YL, Liu DD, et al. Neural progenitor cells resist excitatory amino acid-induced neurotoxicity. J Neurosci Res. 2003;71:272-278.
11. Brazel CY, Nunez JL, Yang Z, Levison SW. Glutamate enhances survival and proliferation of neural progenitors derived from the subventricular zone. Neuroscience. 2005;131:55-65.
12. Candelario KM, Shuttleworth CW, Cunningham LA. Neural stem/progenitor cells display a low requirement for oxidative metabolism independent of hypoxia inducible factor-1alpha expression. J Neurochem. 2013;125: 420-429.
13. Tator CH, Fehlings MG. Review of the secondary injury theory of acute spinal cord trauma with emphasis on vascular mechanisms. J Neurosurg. 1991;75:15-26.
14. Anderson DK, Hall ED. Pathophysiology of spinal cord trauma. Ann Emerg Med. 1993;22:987-992.
15. Liu D, Liu J, Sun D, Wen J. The time course of hydroxyl radical formation following spinal cord injury: the possible role of the iron-catalyzed Haber-Weiss reaction. J Neurotrauma. 2004;21:805-816.
16. Xu W, Chi L, Xu R, et al. Increased production of reactive oxygen species contributes to motor neuron death in a compression mouse model of spinal cord injury. Spinal Cord. 2005;43:204-213.
17. Hall ED. Antioxidant therapies for acute spinal cord injury. Neurotherapeutics. 2011;8:152-167.
18. Le Belle JE, Orozco NM, Paucar AA, et al. Proliferative neural stem cells have high endogenous ROS levels that regulate self-renewal and neurogenesis in a PI3K/Akt-dependant manner. Cell Stem Cell. 2011;8:59-71.
19. Perez Estrada C, Covacu R, Sankavaram SR, et al. Oxidative stress increases neurogenesis and oligodendrogenesis in adult neural progenitor cells. Stem Cells Dev. 2014;23:2311-2327.
20. Guo YL, Chakraborty S, Rajan SS, et al. Effects of oxidative stress on mouse embryonic stem cell proliferation, apoptosis, senescence, and selfrenewal. Stem Cells Dev. 2010;19:1321-1331.
21. Lee HJ, Kim MK, Kim HJ, Kim SU. Human neural stem cells genetically modified to overexpress Akt1 provide neuroprotection and functional improvement in mouse stroke model. PLoS One. 2009;4:e5586.
22. Sakata H, Niizuma K, Yoshioka H, et al. Minocycline-preconditioned neural stem cells enhance neuroprotection after ischemic stroke in rats. J Neurosci. 2012;32:3462-3473.
23. Lin HJ, Wang X, Shaffer KM, et al. Characterization of H2O2-induced acute apoptosis in cultured neural stem/progenitor cells. FEBS Lett. 2004;570:102-106.
24. Konyalioglu S, Armagan G, Yalcin A, et al. Effects of resveratrol on hydrogen peroxide-induced oxidative stress in embryonic neural stem cells. Neural Regeneration Research. 2013;8:485-495.
25. Wang FW, Wang Z, Zhang YM, et al. Protective effect of melatonin on bone marrow mesenchymal stem cells against hydrogen peroxideinduced apoptosis in vitro. J Cell Biochem. 2013;114:2346-2355.
26. Hunt J, Cheng A, Hoyles A, et al. Cyclosporin A has direct effects on adult neural precursor cells. J Neurosci. 2010;30:2888-2896.
27. Binder DK, Scharfman HE. Brain-derived neurotrophic factor. Growth Factors. 2004;22:123-131.
28. Hashimoto T, Fukuda N. Effect of thyrotropin-releasing hormone on the time course of neurologic recovery after spinal cord injury in the rat. Jpn J Pharmacol. 1990;53:479-486.
29. Pitts LH, Ross A, Chase GA, Faden AI. Treatment with thyrotropinreleasing hormone (TRH) in patients with traumatic spinal cord injuries. J Neurotrauma. 1995;12:235-243.
30. Mothe AJ, Kulbatski I, Parr A, et al. Adult spinal cord stem/progenitor cells transplanted as neurospheres preferentially differentiate into oligodendrocytes in the adult rat spinal cord. Cell Transplant. 2008;17:735-751.
31. Guo X, Zahir T, Mothe A, et al. The effect of growth factors and soluble Nogo-66 receptor protein on transplanted neural stem/progenitor survival and axonal regeneration after complete transection of rat spinal cord. Cell Transplant. 2012;21:1177-1197.
32. Michaels RL, Rothman SM. Glutamate neurotoxicity in vitro: antagonist pharmacology and intracellular calcium concentrations. J Neurosci. 1990;10:283-292.
33. Madhavan L, Ourednik V, Ourednik J. Increased ''vigilance'' of antioxidant mechanisms in neural stem cells potentiates their capability to resist oxidative stress. Stem Cells. 2006;24:2110-2119.
34. Ryter SW, Kim HP, Hoetzel A, et al. Mechanisms of cell death in oxidative stress. Antioxid Redox Signal. 2007;9:49-89.
35. Young KM, Merson TD, Sotthibundhu A, et al. p75 neurotrophin receptor expression defines a population of BDNF-responsive neurogenic precursor cells. J Neurosci. 2007;27:5146-5155.
36. Nakamura M, Tsuji O, Bregman BS, et al. Mimicking the neurotrophic factor profile of embryonic spinal cord controls the differentiation potential of spinal progenitors into neuronal cells. PLoS One. 2011;6:e20717.
37. Lameu C, Trujillo CA, Schwindt TT, et al. Interactions between the NOcitrulline cycle and brain-derived neurotrophic factor in differentiation of neural stem cells. J Biol Chem. 2012;287:29690-29701.
38. Islam O, Loo TX, Heese K. Brain-derived neurotrophic factor (BDNF) has proliferative effects on neural stem cells through the truncated TRK-B receptor, MAP kinase, AKT, and STAT-3 signaling pathways. Curr Neurovasc Res. 2009;6:42-53.
39. Zhang Q, Liu G, Wu Y, et al. BDNF promotes EGF-induced proliferation and migration of human fetal neural stem/progenitor cells via the PI3K/Akt pathway. Molecules. 2011;16:10146-10156.
40. Chen SQ, Cai Q, Shen YY, et al. Combined use of NGF/BDNF/bFGF promotes proliferation and differentiation of neural stem cells in vitro. Int J Dev Neurosci. 2014;38c:74-78.
41. Petridis AK, El Maarouf A. Brain-derived neurotrophic factor levels influence the balance of migration and differentiation of subventricular zone cells, but not guidance to the olfactory bulb. J Clin Neurosci. 2011;18:265-270.
42. Arsenijevic Y, Weiss S. Insulin-like growth factor-I is a differentiation factor for postmitotic CNS stem cell-derived neuronal precursors: distinct actions from those of brain-derived neurotrophic factor. J Neurosci. 1998;18:2118-2128.
43. Lim JY, Park SI, Oh JH, et al. Brain-derived neurotrophic factor stimulates the neural differentiation of human umbilical cord blood-derived mesenchymal stem cells and survival of differentiated cells through MAPK/ERK and PI3K/Akt-dependent signaling pathways. J Neurosci Res. 2008;86:2168-2178.
44. Casalbore P, Barone I, Felsani A, et al. Neural stem cells modified to express BDNF antagonize trimethyltin-induced neurotoxicity through PI3K/Akt and MAP kinase pathways. J Cell Physiol. 2010;224:710-721.
45. Nagahara AH, Tuszynski MH. Potential therapeutic uses of BDNF in neurological and psychiatric disorders. Nat Rev Drug Discov. 2011; 10:209-219.
46. Nguyen N, Lee SB, Lee YS, et al. Neuroprotection by NGF and BDNF against neurotoxin-exerted apoptotic death in neural stem cells are mediated through Trk receptors, activating PI3-kinase and MAPK pathways. Neurochem Res. 2009;34:942-951.
47. Shukla A, Mohapatra TM, Agrawal AK, et al. Salsolinol induced apoptotic changes in neural stem cells: amelioration by neurotrophin support. Neurotoxicology. 2013;35:50-61.
48. Yoo YM, Kim YJ, Lee U. The change of the neuron-glia differentiation rate in human neural precursor cells (HPCs) and Ad-BDNF-/-GDNF-infected HPCs following the administration of a neurotoxin. Neurosci Lett. 2005;387:100-104.
49. Hayes JD, McLellan LI. Glutathione and glutathione-dependent enzymes represent a co-ordinately regulated defence against oxidative stress. Free Radic Res. 1999;31:273-300.
50. Spina MB, Squinto SP, Miller J, et al. Brain-derived neurotrophic factor protects dopamine neurons against 6-hydroxydopamine and N-methyl-4-phenylpyridinium ion toxicity: involvement of the glutathione system. J Neurochem. 1992;59:99-106.
51. Mattson MP, Lovell MA, Furukawa K, Markesbery WR. Neurotrophic factors attenuate glutamate-induced accumulation of peroxides, elevation of intracellular Ca2 + concentration, and neurotoxicity and increase antioxidant enzyme activities in hippocampal neurons. J Neurochem. 1995;65:1740-1751.
52. Boyadjieva NI, Sarkar DK. Cyclic adenosine monophosphate and brainderived neurotrophic factor decreased oxidative stress and apoptosis in developing hypothalamic neuronal cells: role of microglia. Alcohol Clin Exp Res. 2013;37:1370-1379.
53. He T, Katusic ZS. Brain-derived neurotrophic factor increases expression of MnSOD in human circulating angiogenic cells. Microvasc Res. 2012;83:366-371.
54. Ikeda O, Murakami M, Ino H, et al. Effects of brain-derived neurotrophic factor (BDNF) on compression-induced spinal cord injury: BDNF attenuates down-regulation of superoxide dismutase expression and promotes up-regulation of myelin basic protein expression. J Neuropathol Exp Neurol. 2002;61:142-153.
55. Rosenblum S, Smith TN, Wang N, et al. BDNF Pre-treatment of Human Embryonic-Derived Neural Stem Cells Improves Cell Survival and Functional Recovery after Transplantation in Hypoxic-Ischemic Stroke. Cell Transplant. 2014 Mar 3. [Epub ahead of print].
56. Hunt J, Morshead C. Cyclosporin A Enhances Cell Survival in Neural Precursor Populations in the Adult Central Nervous System. PharmSight. 2010;2:81-88.
57. McEwen ML, Sullivan PG, Springer JE. Pretreatment with the cyclosporin derivative, NIM811, improves the function of synaptic mitochondria following spinal cord contusion in rats. J Neurotrauma. 2007;24:613-624.
58. Gill RS, Lee TF, Liu JQ, et al. Cyclosporine treatment reduces oxygen free radical generation and oxidative stress in the brain of hypoxia-reoxygenated newborn piglets. PLoS One. 2012;7:e40471.
59. Mbye LH, Singh IN, Sullivan PG, et al. Attenuation of acute mitochondrial dysfunction after traumatic brain injury in mice by NIM811, a non-immunosuppressive cyclosporin A analog. Exp Neurol. 2008;209:243-253.
60. Ott M, Gogvadze V, Orrenius S, Zhivotovsky B. Mitochondria, oxidative stress and cell death. Apoptosis. 2007;12:913-922.
61. Wagh V, Meganathan K, Jagtap S, et al. Effects of cryopreservation on the transcriptome of human embryonic stem cells after thawing and culturing. Stem Cell Rev. 2011;7:506-517.